Document is current
Any future updates will be listed below
-
Authors
Curtis, Deven P.
Salmen, Natasha L.
Baumann, Anthony N.
Busby, Justine F.
Brodell, Robert T.
- License Information
-
More Information
Article History
Received: 28 November 2024
Revised: 28 November 2024
Accepted: 3 January 2025
First Online: 16 January 2025
Declarations
:
: The authors declare no competing interests.
: Robert Brodell, M.D. discloses the following potential conflicts of interest: Advisory boards: Novan and Amgen. Research funding: Pfizer, Novartis, and Sanofi. Stock: Veragen, Inc. Deven P. Curtis, Natasha L. Salmen, Anthony N. Baumann, Justine F. Busby and Eliot N. Mostow have no conflicts to disclose.
